175 related articles for article (PubMed ID: 21318053)
1. DNA hypermethylation markers of poor outcome in laryngeal cancer.
Stephen JK; Chen KM; Shah V; Havard S; Kapke A; Lu M; Benninger MS; Worsham MJ
Clin Epigenetics; 2010 Sep; 1(1-2):61-69. PubMed ID: 21318053
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
3. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
He L; Ji W; Yang J; Zhao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus outcomes in an access-to-care laryngeal cancer cohort.
Stephen JK; Chen KM; Shah V; Havard S; Lu M; Schweitzer VP; Gardner G; Worsham MJ
Otolaryngol Head Neck Surg; 2012 May; 146(5):730-8. PubMed ID: 22267491
[TBL] [Abstract][Full Text] [Related]
5. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
6. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.
Shen Z; Cao B; Lin L; Zhou C; Ye D; Qiu S; Li Q; Cui X
Med Sci Monit; 2017 Jul; 23():3635-3640. PubMed ID: 28743857
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of
Cheng L; Shen Z; Zhou C
Int J Clin Exp Pathol; 2017; 10(12):11635-11643. PubMed ID: 31966521
[TBL] [Abstract][Full Text] [Related]
9. [Aberrant expression of CyclinE and p27 in laryngeal squamous cell carcinoma and the clinical significance].
Chai D; Bao Z; Hu J; Ma L; Feng Z; Tao Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(3):165-9, 174. PubMed ID: 24826452
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
Fang R; Huang Y; Xie J; Zhang J; Ji X
Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
12.
Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
[TBL] [Abstract][Full Text] [Related]
13. Standardised Ki-67 proliferation index assessment in early-stage laryngeal squamous cell carcinoma in relation to local control and survival after primary radiotherapy.
Kop E; de Bock GH; Noordhuis MG; Slagter-Menkema L; van der Laan BFAM; Langendijk JA; Schuuring E; van der Vegt B
Clin Otolaryngol; 2020 Jan; 45(1):12-20. PubMed ID: 31561282
[TBL] [Abstract][Full Text] [Related]
14. Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma.
Wang W; Lin P; Han C; Cai W; Zhao X; Sun B
J Exp Clin Cancer Res; 2010 Jun; 29(1):60. PubMed ID: 20525189
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
17. Molecular differentiation of early and late stage laryngeal squamous cell carcinoma: an exploratory analysis.
Saglam O; Shah V; Worsham MJ
Diagn Mol Pathol; 2007 Dec; 16(4):218-21. PubMed ID: 18043285
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
Huang C; Zhou X; Li Z; Liu H; He Y; Ye G; Huang K
Mol Med Rep; 2016 Sep; 14(3):2489-96. PubMed ID: 27485791
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.
Tang D; Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Xie M; Cheng L
Acta Otolaryngol; 2018 Nov; 138(11):1043-1050. PubMed ID: 30776268
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma.
Meng W; Cui W; Zhao L; Chi W; Cao H; Wang B
J Biomed Sci; 2019 Jan; 26(1):13. PubMed ID: 30684967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
